부산대학교 도서관

In Urologic Oncology: Seminars and Original Investigations January 2013 31(1):127-127

In Urologic Oncology: Seminars and Original Investigations 2008 26(1):100-101

Konety, Badrinath R., M.D.

Urologic Oncology: Seminars and Original Investigations. 24(1):87-88

Novick, Andrew C., M.D.

Urologic Oncology: Seminars and Original Investigations. 23(1):71-72

Staehler, M; Motzer, RJ; George, DJ; Pandha, HS; Donskov, F; Escudier, B; Pantuck, AJ; Patel, A; DeAnnuntis, L; Bhattacharyya, H; Ramaswamy, K; Zanotti, G; Lin, X; Lechuga, M; Serfass, L; Paty, J; Ravaud, A

Annals of Oncology. 29(10)

Davis JW; Shaves ME; Schellhammer PF

Oncology (08909091) (ONCOLOGY (08909091)), 2004 Jun; 18(7): 811-824. (12p)

Faiena I; Columbia University Irving Medical Center, New York, NY.; Adhikary S; Kite, A Gilead Company, Santa Monica, CA.; Schweitzer C; Kite, A Gilead Company, Santa Monica, CA.; Astrow SH; Chimeric Therapeutics, Carlton South, Vic., Australia.; Grogan T; Department of Medicine Statistics Core, David Geffen School of Medicine at UCLA, Los Angeles, CA.; Funt SA; Memorial Sloan Kettering Cancer Center, New York, NY.; Bot A; Capstan Therapeutics, San Diego, CA.; Dorff T; City of Hope Comprehensive Cancer Center, Duarte, CA.; Rosenberg JE; Memorial Sloan Kettering Cancer Center, New York, NY.; Elashoff DA; Department of Medicine Statistics Core, David Geffen School of Medicine at UCLA, Los Angeles, CA.; Pantuck AJ; Institute of Urologic Oncology, David Geffen School of Medicine at UCLA, Los Angeles, CA.; Drakaki A; Institute of Urologic Oncology, David Geffen School of Medicine at UCLA, Los Angeles, CA.

Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 9706083 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1537-4513 (Electronic) Linking ISSN: 15249557 NLM ISO Abbreviation: J Immunother Subsets: MEDLINE

Shuch B; Institute of Urologic Oncology, University of California Los Angeles, Los Angeles, CA, USA. Electronic address: bshuch@mednet.ucla.edu.; Pantuck AJ; Institute of Urologic Oncology, University of California Los Angeles, Los Angeles, CA, USA.; Bernhard JC; Department of Urology, Centre Hospitalier Universitaire de Bordeaux-Groupe Hospitalier Pellegrin, Bordeaux, France.; Morris MA; United Theranostics, Glen Burnie, Baltimore, MD, USA.; Master V; Department of Urology, Emory University School of Medicine, Atlanta, GA, USA.; Scott AM; Department of Molecular Imaging and Therapy, Austin Health, Melbourne, VIC, Australia; Department of Medicine, The University of Melbourne, Melbourne, VIC, Australia; Olivia Newton-John Cancer Research Institute, Melbourne, VIC, Australia; School of Cancer Medicine, La Trobe University, Melbourne, VIC, Australia.; van Praet C; Department of Urology, Ghent University Hospital, Ghent, Belgium.; Bailly C; Department of Nuclear Medicine, Nantes University Hospital, Nantes, France.; Önal B; Department of Urology, Istanbul University-Cerrahpasa, Istanbul, Turkey.; Aksoy T; Department of Nuclear Medicine, Istanbul Training and Research Hospital, Istanbul, Turkey.; Merkx R; Department of Medical Imaging, Nuclear Medicine, Radboud University Medical Center, Nijmegen, Netherlands.; Schuster DM; Department of Radiology and Imaging Sciences, Emory University, Atlanta, GA, USA.; Lee ST; Department of Molecular Imaging and Therapy, Austin Health, Melbourne, VIC, Australia; Department of Medicine, The University of Melbourne, Melbourne, VIC, Australia; Olivia Newton-John Cancer Research Institute, Melbourne, VIC, Australia; School of Cancer Medicine, La Trobe University, Melbourne, VIC, Australia.; Pandit-Taskar N; Memorial Sloan Kettering Cancer Center, New York, NY, USA; Weill Cornell Medical College, New York, NY, USA.; Fan AC; Department of Medicine, Division of Oncology, Stanford University School of Medicine, Stanford, CA, USA.; Allman P; Premier Research, Morrisville, NC, USA.; Schmidt K; ABX-CRO Advanced Pharmaceutical Services Forschungsgesellschaft, Dresden, Germany.; Tauchmanova L; Telix Pharmaceuticals, Melbourne, VIC, Australia.; Wheatcroft M; Telix Pharmaceuticals, Melbourne, VIC, Australia.; Behrenbruch C; Telix Pharmaceuticals, Melbourne, VIC, Australia.; Hayward CRW; Telix Pharmaceuticals, Melbourne, VIC, Australia.; Mulders P; Department of Urology, Radboud University Medical Center, Nijmegen, Netherlands.

Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 100957246 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-5488 (Electronic) Linking ISSN: 14702045 NLM ISO Abbreviation: Lancet Oncol Subsets: MEDLINE

Kathuria-Prakash N; Division of Hematology/Oncology, Department of Medicine, University of California, Los Angeles, Los Angeles, CA.; Lopez LP; Division of Hematology/Oncology, Department of Medicine, University of California, Los Angeles, Los Angeles, CA.; Raman S; Department of Radiology, University of California, Los Angeles, Los Angeles, CA.; Ye H; Department of Pathology, Cedars Sinai Medical Center, Los Angeles, CA.; Anaokar J; Department of Radiology, University of California, Los Angeles, Los Angeles, CA.; Sisk A; Department of Pathology, University of California, Los Angeles, Los Angeles, CA.; Pantuck AJ; Department of Urology, University of California, Los Angeles, Los Angeles, CA.; Drakaki A; Division of Hematology/Oncology, Department of Medicine, University of California, Los Angeles, Los Angeles, CA.

Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101705370 Publication Model: Print Cited Medium: Internet ISSN: 2473-4284 (Electronic) Linking ISSN: 24734284 NLM ISO Abbreviation: JCO Precis Oncol Subsets: MEDLINE

Faiena I; Cummings AL; Crosetti AM; Pantuck AJ; Chamie K; Drakaki A

Drug Design, Development and Therapy, Vol Volume 12, Pp 209-215 (2018)